Rick S W, Topol I A, Erickson J W, Burt S K
Frederick Biomedical Supercomputing Center, SAIC-Frederick, NCI-Frederick Cancer Research and Development Center, Maryland 27102, USA.
Protein Sci. 1998 Aug;7(8):1750-6. doi: 10.1002/pro.5560070809.
The changes in the inhibitor binding constants due to the mutation of isoleucine to valine at position 84 of HIV-1 protease are calculated using molecular dynamics simulations. The calculations are done for three potent inhibitors--KNI-272, L-735,524 (indinavir or MK-639), and Ro 31-8959 (saquinavir). The calculations agree with the experimental data both in terms of an overall trend and in the magnitude of the resulting free energy change. HIV-1 protease is a homodimer, so each mutation causes two changes in the enzyme. The decrease in the binding free energy from each mutated side chain differs among the three inhibitors and correlates well with the size of the cavities induced in the protein interior near the mutated residue. The cavities are created as a result of a mutation to a smaller side chain, but the cavities are less than would be predicted from the wild-type structures, indicating that there is significant relaxation to partially fill the cavities.
利用分子动力学模拟计算了HIV-1蛋白酶84位异亮氨酸突变为缬氨酸导致的抑制剂结合常数变化。对三种强效抑制剂——KNI-272、L-735,524(茚地那韦或MK-639)和Ro 31-8959(沙奎那韦)进行了计算。计算结果在总体趋势和产生的自由能变化幅度方面均与实验数据相符。HIV-1蛋白酶是一种同二聚体,因此每次突变都会在酶中引起两处变化。三种抑制剂中,每个突变侧链导致的结合自由能降低情况不同,且与突变残基附近蛋白质内部诱导产生的空穴大小密切相关。空穴是由突变为较小侧链导致的,但空穴比野生型结构预测的要小,这表明存在显著的松弛以部分填充空穴。